Solaris Resources Inc. (CVE:SLS) to Post FY2024 Earnings of ($0.45) Per Share, HC Wainwright Forecasts

Solaris Resources Inc. (CVE:SLS) – Research analysts at HC Wainwright issued their FY2024 earnings estimates for shares of Solaris Resources in a note issued to investors on Monday, August 12th. HC Wainwright analyst H. Ihle expects that the company will post earnings per share of ($0.45) for the year. HC Wainwright currently has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for Solaris Resources’ FY2025 earnings at ($0.47) EPS.

Other equities analysts also recently issued research reports about the company. National Bank Financial raised Solaris Resources to a “strong-buy” rating in a research report on Monday, June 10th. Maxim Group raised shares of Solaris Resources to a “strong-buy” rating in a research note on Wednesday, July 3rd.

Solaris Resources Trading Down 2.7 %

Shares of SLS stock opened at C$6.15 on Wednesday. Solaris Resources has a 1 year low of C$1.38 and a 1 year high of C$7.09. The company’s 50 day moving average is C$6.15.

Solaris Resources Company Profile

SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.